Chiasma Secures $5,115,000 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    831 Beacon St. Newton Center, MA 02459
  • Company Description
    Chiasma develops innovative solutions for the non-invasive delivery of protein drugs. Chiasma’s technology enables drugs to be administered into the bloodstream without the need for injections.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy